Discovered by Dr. Payne while at Wake Forest Baptist Medical Center, CTI-1601 (TAT-frataxin) utilizes a carrier protein to deliver frataxin, the deficient protein in Friedreich’s Ataxia, to the mitochondria where researchers believe it is processed to mature frataxin and becomes active in mitochondrial metabolism.

Read the full Press Release HERE